Hikma Pharmaceuticals PLC (OTCMKTS:HKMPY – Get Free Report)’s stock price was up 1.4% during mid-day trading on Wednesday. The company traded as high as $47.75 and last traded at $47.75. 101 shares traded hands during trading, a decline of 91% from the average session volume of 1,176 shares. The stock had previously closed at $47.0850.
Hikma Pharmaceuticals Stock Up 1.4%
The company has a fifty day simple moving average of $43.28 and a 200 day simple moving average of $40.65.
Hikma Pharmaceuticals Company Profile
Hikma Pharmaceuticals plc is a multinational pharmaceutical company that develops, manufactures and markets a broad range of medicines. Its portfolio includes generic, branded and specialty pharmaceutical products, as well as injectable medicines used in hospitals and other healthcare settings.
The company serves healthcare providers, pharmacies and patients across the United States, Europe, the Middle East and North Africa, and other international markets. Its products cover a variety of therapeutic areas, with operations spanning prescription medicines, hospital injectables and established branded treatments.
Hikma was founded in Jordan in 1978 by Samih Darwazah and has expanded into a global pharmaceutical business through organic growth and acquisitions.
Recommended Stories
- Five stocks we like better than Hikma Pharmaceuticals
- Why ExxonMobil and Chevron Reminded Investors to Keep it Simple
- Amazon Has Erased Its Earnings Sell-Off, But Is the Biggest Opportunity Still Ahead?
- onsemi’s AI Sales Surge 175%: Is a Stock Recovery Next?
- Energy Transfer’s Earnings Miss May Be Hiding Its Strongest Advantage
Receive News & Ratings for Hikma Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hikma Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
